Michael H. Davidson to Cholinesterase Inhibitors
This is a "connection" page, showing publications Michael H. Davidson has written about Cholinesterase Inhibitors.
Connection Strength
0.469
-
Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study. Arch Gerontol Geriatr. 2004 Jan-Feb; 38(1):61-8.
Score: 0.241
-
Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatr Scand Suppl. 1991; 366:47-51.
Score: 0.098
-
Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. Dement Geriatr Cogn Disord. 2003; 15(2):79-87.
Score: 0.056
-
Long-term safety of risperidone. J Clin Psychiatry. 2001; 62 Suppl 21:26-8.
Score: 0.049
-
The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Psychiatr Clin North Am. 1991 Jun; 14(2):461-82.
Score: 0.025